AtPulse Information

AtPulse is a Danish-born deep-tech health company developing AI‑driven, clinically aligned solutions for chronic care. We focus on diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD), combining advanced analytics with Scandinavian design principles to create tools that are intuitive, evidence‑based, and built for real‑world impact. Our technology supports earlier intervention, clearer decision‑making, and more efficient care delivery. Every solution is developed in close collaboration with clinicians and researchers to ensure safety, transparency, and alignment with established care pathways. We believe AI should enhance—not replace—the human connection at the heart of healthcare. For partners and health systems, we offer interoperable, scalable solutions that integrate smoothly into existing workflows. For investors, we address one of the world’s largest and fastest‑growing healthcare challenges with a model designed for global deployment and long‑term sustainability. Operating across Europe and ASEAN, we work with hospitals, research institutions, and organizations committed to improving chronic care through innovation, empathy, and responsible technology.